AU2002212292A1 - Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules - Google Patents
Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid moleculesInfo
- Publication number
- AU2002212292A1 AU2002212292A1 AU2002212292A AU1229202A AU2002212292A1 AU 2002212292 A1 AU2002212292 A1 AU 2002212292A1 AU 2002212292 A AU2002212292 A AU 2002212292A AU 1229202 A AU1229202 A AU 1229202A AU 2002212292 A1 AU2002212292 A1 AU 2002212292A1
- Authority
- AU
- Australia
- Prior art keywords
- ephrin
- eph
- ligands
- receptors
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1910/00 | 2000-09-29 | ||
CH19102000 | 2000-09-29 | ||
PCT/EP2001/011252 WO2002026827A1 (en) | 2000-09-29 | 2001-09-28 | Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002212292A1 true AU2002212292A1 (en) | 2002-04-08 |
Family
ID=4566752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002212292A Abandoned AU2002212292A1 (en) | 2000-09-29 | 2001-09-28 | Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002212292A1 (en) |
WO (1) | WO2002026827A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6887674B1 (en) | 1998-04-13 | 2005-05-03 | California Institute Of Technology | Artery- and vein-specific proteins and uses therefor |
US6864227B1 (en) | 1998-04-13 | 2005-03-08 | California Institute Of Technology | Artery-and vein-specific proteins and uses therefor |
CA2452578A1 (en) * | 2001-07-03 | 2003-01-16 | The Hospital For Sick Children | Ephrin and eph receptor mediated immune modulation |
AU2002951409A0 (en) * | 2002-09-16 | 2002-09-26 | North Western Adelaide Health Services | Methods for regulating cancer |
JP2006507256A (en) | 2002-09-24 | 2006-03-02 | ザ バーナム インスティチュート | Novel drug that modulates Eph receptor activity |
AU2004210463B2 (en) * | 2003-02-07 | 2009-07-16 | Ludwig Institute For Cancer Research Limited | Eph/ephrin mediated modulation of cell adhesion and tumour cell metastasis |
AU2003900541A0 (en) * | 2003-02-07 | 2003-02-20 | Ludwig Institute For Cancer Research | Modulation of cell adhesion and tumour cell metastasis |
AU2004220459B2 (en) | 2003-03-12 | 2010-08-05 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
US7381410B2 (en) | 2003-03-12 | 2008-06-03 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
CN1921892A (en) * | 2003-10-17 | 2007-02-28 | 艾克蒂斯生物公司 | Lentiviral vector delivery of msp36 for treatment of cancer |
EP1526380A1 (en) * | 2003-10-21 | 2005-04-27 | Progenika Biopharma, S.A. | Methods for in vitro diagnosis and in vitro prognosis of cancer of the pancreas and for the development of drugs against cancer of the pancreas |
JP2007516727A (en) * | 2003-12-31 | 2007-06-28 | アクティス バイオロジクス, インコーポレイテッド | Lentiviral vector delivery of native IGFBP-3 and mutant IGFBP-3 to treat cancer |
AU2005224081B2 (en) | 2004-03-12 | 2011-06-30 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
CN102746401A (en) | 2004-03-12 | 2012-10-24 | 瓦斯基因治疗公司 | Polypeptide compound for inhibiting angiogenesis and tumor growth |
WO2006006079A2 (en) * | 2004-04-05 | 2006-01-19 | Aqumen Biopharmaceuticals K.K. | Methods for suppressing neovascularization using ephrinb2 |
EP1745073A2 (en) * | 2004-05-14 | 2007-01-24 | Receptor Biologix, Inc. | Cell surface receptor isoforms and methods of identifying and using the same |
US20060204512A1 (en) * | 2004-09-23 | 2006-09-14 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
DE602006017964D1 (en) * | 2005-01-27 | 2010-12-16 | Burnham Inst La Jolla | EPHB RECEPTOR BINDING PEPTIDES |
WO2007005244A1 (en) * | 2005-07-05 | 2007-01-11 | The Regents Of The University Of California | Henipavirus receptor and uses thereof |
CA2623563A1 (en) * | 2005-10-05 | 2007-04-19 | Aqumen Biopharmaceuticals K.K. | Method of inhibiting angiogenesis by using ephrin b2 |
JP2009221107A (en) * | 2006-05-24 | 2009-10-01 | Aqumen Biopharmaceuticals Kk | Peptide enhancing ephrin b2 activity, its salt, medicinal composition and kit for treating |
CA2696164C (en) | 2007-08-13 | 2018-06-12 | Vasgene Therapeutics, Inc. | Cancer treatment using humanized antibodies that bind to ephb4 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69334100T2 (en) * | 1992-11-13 | 2007-07-19 | Immunex Corp., Seattle | ELK LIGAND, A CYTOKIN |
US6303769B1 (en) * | 1994-07-08 | 2001-10-16 | Immunex Corporation | Lerk-5 dna |
US5864020A (en) * | 1994-07-20 | 1999-01-26 | Genentech, Inc. | HTK ligand |
WO1996026958A2 (en) * | 1995-02-27 | 1996-09-06 | President And Fellows Of Harvard College | Eph RECEPTOR LIGAND ELF-2 |
AU9594598A (en) * | 1997-10-02 | 1999-04-27 | Millennium Pharmaceuticals, Inc. | Modulation of lerk-2-mediated cell adhesion |
ATE293989T1 (en) * | 1998-11-20 | 2005-05-15 | Genentech Inc | USE OF EPH RECEPTOR ANTAGONISTS AND AGONISTS FOR THE TREATMENT OF VASCULAR DISEASES |
-
2001
- 2001-09-28 WO PCT/EP2001/011252 patent/WO2002026827A1/en active Application Filing
- 2001-09-28 AU AU2002212292A patent/AU2002212292A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002026827A1 (en) | 2002-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002212292A1 (en) | Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules | |
AU2002366951A1 (en) | Novel nucleic acids and polypeptides | |
AU2002326877A1 (en) | Novel nucleic acids and polypeptides | |
AU2002314709A1 (en) | Novel nucleic acids and polypeptides | |
AU2002362592A1 (en) | Bgl3 beta-glucosidase and nucleic acids encoding the same | |
AU2002356869A1 (en) | Bgl4 beta-glucosidase and nucleic acids encoding the same | |
AU2002357681A1 (en) | Egvii endoglucanase and nucleic acids encoding the same | |
AU2001249251A1 (en) | Novel nucleic acids and polypeptides | |
AU2001243142A1 (en) | Novel nucleic acids and polypeptides | |
AU2001234944A1 (en) | Novel nucleic acids and polypeptides | |
AU2001290548A1 (en) | Novel nucleic acids and polypeptides | |
AU2001245280A1 (en) | Novel nucleic acids and polypeptides | |
AU2001233041A1 (en) | Novel nucleic acids and polypeptides | |
AU2001238347A1 (en) | Novel nucleic acids and polypeptides | |
AU2001268028A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2001296235A1 (en) | Novel nucleic acids and polypeptides | |
AU2001265311A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2001263006A1 (en) | Novel nucleic acids and polypeptides | |
AU2001233017A1 (en) | Novel nucleic acids and polypeptides | |
AU2002343417A1 (en) | Novel nucleic acids and polypeptides | |
AU2001241511A1 (en) | Novel nucleic acids and polypeptides | |
AU2001250872A1 (en) | Novel nucleic acids and polypeptides | |
AU2001277840A1 (en) | Novel nucleic acids and polypeptides | |
AU2001264852A1 (en) | Lactobacillusbeta -glucuronidase and dna encoding the same | |
AU2002250419A1 (en) | Novel nucleic acids and polypeptides |